Published in Br J Haematol on July 01, 1979
Cloning of the gene coding for human L apoferritin. Nucleic Acids Res (1986) 2.31
Serum ferritin: Past, present and future. Biochim Biophys Acta (2010) 1.80
Structure of human ferritin light subunit messenger RNA: comparison with heavy subunit message and functional implications. Proc Natl Acad Sci U S A (1985) 1.79
TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J Exp Med (2005) 1.52
Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages. J Exp Med (1981) 1.20
Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem (2011) 1.16
Abnormalities in the immune system of children with beta-thalassaemia major. Clin Exp Immunol (1987) 1.09
Duodenal iron proteins in idiopathic hemochromatosis. J Clin Invest (1989) 1.01
Iron uptake mediated by binding of H-ferritin to the TIM-2 receptor in mouse cells. PLoS One (2011) 0.89
MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled. World J Gastroenterol (2013) 0.88
Ferritin blocks inhibitory effects of two-chain high molecular weight kininogen (HKa) on adhesion and survival signaling in endothelial cells. PLoS One (2012) 0.84
The effect of iron (Fe3+) on the cloning efficiency of human memory T4+ lymphocytes. Clin Exp Immunol (1986) 0.81
The effect of experimental iron-overload on splenic T cell function: analysis using cloning techniques. Clin Exp Immunol (1987) 0.80
Alloimmunization to Red Cells and the Association of Alloantibodies Formation with Splenectomy Among Transfusion-Dependent β-Thalassemia Major/HbE Patients. Indian J Clin Biochem (2014) 0.77
Modulation of the defective natural killer activity seen in thalassaemia major with desferrioxamine and alpha-interferon. Clin Exp Immunol (1987) 0.77
Anti-T cell immunoglobulin and mucin domain-2 monoclonal antibody exacerbates collagen-induced arthritis by stimulating B cells. Arthritis Res Ther (2011) 0.76
Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer. Br J Cancer (1988) 0.75
Impaired polymorphonuclear leukocyte function in chronically hemodialyzed patients with iron overload. Korean J Intern Med (1988) 0.75
Identification of human B and T lymphocytes by scanning electron microscopy. J Exp Med (1973) 3.21
Development of oral iron chelator L1. Lancet (1993) 2.74
Diagnosis of familial Mediterranean fever by a molecular genetics method. Ann Intern Med (1998) 2.21
Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol (2000) 2.11
Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol (1978) 2.07
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer (1976) 1.97
Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol (2001) 1.94
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 1.79
Image-guided core-needle biopsy in malignant lymphoma: experience with 100 patients that suggests the technique is reliable. J Clin Oncol (1996) 1.78
Ichthyosiform dermatosis with systemic lipidosis. Arch Dermatol (1974) 1.69
The familial Mediterranean fever gene--cloned at last. N Engl J Med (1997) 1.62
Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. N Engl J Med (1993) 1.51
Lead poisoning in a West Bank Arab Village. Arch Intern Med (1984) 1.49
Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release. Br J Haematol (1977) 1.48
The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci (2000) 1.44
Lymphoma and systemic sclerosis--an uncommon association or possible coincidence of two disorders with a fatal outcome. Eur J Haematol (1997) 1.42
Partial resistance to anticoagulation after streptokinase treatment for acute myocardial infarction. Am J Cardiol (1990) 1.40
Clinical problem-solving. Assembling a coherent story. N Engl J Med (1994) 1.40
Clomiphene as a novel modality for the treatment of acute myeloid leukemia: A pilot phase II study. Leuk Res (2011) 1.40
Laparoscopic splenectomy for immune thrombocytopenic purpura. J Laparoendosc Surg (1996) 1.39
Value of lymphangiography in the staging of Hodgkin lymphoma. Radiology (1994) 1.38
Storage iron kinetics. VI. The effect of inflammation on iron exchange in the rat. Br J Haematol (1974) 1.33
Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett (2001) 1.29
Continuous production of monoclonal rheumatoid factor by EBV-transformed lymphocytes. Nature (1980) 1.29
MEFV mutations in Turkish patients suffering from Familial Mediterranean Fever. Hum Mutat (2000) 1.28
Destructive bone lesions in primary amyloidosis. Postgrad Med J (1986) 1.27
Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. J Clin Invest (1985) 1.27
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood (1987) 1.26
Immunofluorescent demonstration of enteropathogenic Escherichia coli in tissues of infants dying with enteritis. Pediatrics (1970) 1.25
Pulmonary involvement in lymphoma. Leuk Lymphoma (1996) 1.23
Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options. Ann Oncol (2013) 1.23
Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J Histochem Cytochem (1998) 1.22
The changing clinical spectrum of liver abscess: the Jerusalem experience. Postgrad Med J (1994) 1.15
HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome. Am J Med (1987) 1.15
Association of a chromosomal abnormality with lymphocytes having both T and B markers in a patient with lymphoproliferative disease. Am J Med (1976) 1.15
Quality of life and survival following intensive medical care. Q J Med (1989) 1.14
Scanning electron microscopy of murine macrophages. Surface characteristics during maturation, activation, and phagocytosis. Lab Invest (1975) 1.14
Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol (2005) 1.12
The liver in amyloidosis. Digestion (1974) 1.11
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol (1995) 1.09
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood (1996) 1.08
Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids. Cancer Res (1982) 1.08
Storage iron kinetics. II. The uptake of hemoglobin iron by hepatic parenchymal cells. J Lab Clin Med (1972) 1.07
CT-guided biopsy with cutting-edge needle for the diagnosis of malignant lymphoma: experience of 267 biopsies. Clin Radiol (2003) 1.07
Systemic leishmaniasis mimicking malignant histiocytosis. Cancer (1979) 1.05
Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma. Clin Chem (1986) 1.04
Hepatocellular uptake of ferritin in the rat. Br J Haematol (1974) 1.03
Potentiating effect of vitamin A on 9-10 dimethyl 1-2 benzanthracene--carcinogenesis in the hamster cheek pouch. Cancer (1968) 1.03
Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders. Am J Clin Pathol (1981) 1.03
Results of long-term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators. Br J Haematol (1995) 1.03
Storage iron kinetics. 3. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cells. J Lab Clin Med (1973) 1.02
Synthesis of liver ferritin on free and membrane-bound polyribosomes of different sizes. FEBS Lett (1973) 1.02
Integrative oncology in the Middle East: from traditional herbal knowledge to contemporary cancer care. Ann Oncol (2011) 1.00
Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture. J Lab Clin Med (2001) 1.00
Decreased fibrinolysis in Behçet's disease. Thromb Diath Haemorrh (1973) 0.99
Cutaneous lymphoma in Israel, 1985-1993: a population-based incidence study. Br J Cancer (1998) 0.99
Human prothymocytes. Membrane properties, differentiation patterns, glucocorticoid sensitivity, and ultrastructural features. J Exp Med (1980) 0.99
Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. Ann Oncol (2010) 0.99
Inhibition of chemical carcinogenesis in the hamster cheek pouch by topical chlorpromazine. Nature (1970) 0.98
Scanning electron microscopy of human lymphocyte-sheep erythrocyte rosettes. J Exp Med (1974) 0.98
Heart cells in culture: a model of myocardial iron overload and chelation. J Lab Clin Med (1985) 0.98
The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Thromb Haemost (1984) 0.97
Sudden onset deafness as a presenting manifestation of chronic lymphocytic leukemia. Leuk Lymphoma (1993) 0.97
Thiamine deficiency in patients with B-chronic lymphocytic leukaemia: a pilot study. Postgrad Med J (2001) 0.97
Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells. J Lab Clin Med (1998) 0.96
Studies on the hypercoagulable state. The regulation of fibrinogen production in experimental hyper- and hypofibrinogenemia. Thromb Diath Haemorrh (1968) 0.96
Antimalarial effect of HBED and other phenolic and catecholic iron chelators. Blood (1989) 0.96
Pulmonary involvement as the major manifestation of chronic lymphocytic leukemia. Leuk Lymphoma (1992) 0.96
Reversible central nervous system dysfunction in folate deficiency. J Neurol Sci (1975) 0.96
Coexistence of myelomonocytic leukemia and monoclonal gammopathy or myeloma. Simultaneous presentation in three patients. Cancer (1984) 0.95
Ethnical and clinical aspects of chronic lymphocytic leukemia in Israel: a survey on 288 patients. Acta Haematol (1978) 0.95
CT-guided core-needle biopsy in the diagnosis of mediastinal lymphoma. Eur Radiol (2000) 0.94
Paracetamol-induced thrombocytopenia and haemolytic anaemia. Lancet (1978) 0.94
Widespread Castleman disease: CT and US findings. Radiology (1988) 0.94
C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med (1984) 0.94
Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever. Blood (1984) 0.94
Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia. Am J Hematol (1980) 0.93
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma. Ann Oncol (2009) 0.93
Plasmacytoma of the breast. Unusual initial presentation of myeloma: report of two cases and review of the literature. Blut (1989) 0.93
The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood (2000) 0.93
The effect of topical vitamin A on papillomas and intraepithelial carcinomas induced in hamster cheek pouches with 9,10-dimethyl-1,2-benzanthracene. Cancer Res (1969) 0.93
Metabolic effects of pyrimidines derived from fava bean glycosides on human erythrocytes deficient in glucose-6-phosphate dehydrogenase. Biochem Biophys Res Commun (1965) 0.93
The effect of erythropoietin on synchronized rabbit hemopoietic tissue in culture. Blood (1972) 0.93
Mechanism of iron induction of ferritin synthesis. Biochem Biophys Res Commun (1975) 0.93
Storage iron kinetics. V. Iron exchange in the rat. Br J Haematol (1973) 0.93
Effect of zinc therapy on neutrophil chemotaxis in psoriasis. Isr J Med Sci (1990) 0.93
Cancer patterns in the Middle East--special report from the Middle East Cancer Society. Acta Oncol (1997) 0.93
The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study. Cancer (2000) 0.93
ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia. Blood (1999) 0.92